Simulations Plus has partnered with an unnamed clinical-stage biotech company to develop a new delivery model using its GastroPlus software, the company announced Wednesday.

The Lancaster drug simulation company hopes the funded collaboration will improve drug dosing into joints, Simulations said in a statement...

Join our Membership to get the full story.


Are you a current Member? Sign In